Stay updated with breaking news from Thomas Catinazzo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) CFO Thomas Catinazzo sold 1,695 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $6.38, for a total transaction of $10,814.10. Following the transaction, the chief financial officer now directly owns 339,803 shares […]
Relay Therapeutics (NASDAQ:RLAY – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. The brokerage currently has a $31.00 price target on the stock. Zacks Investment Research‘s price objective would suggest a potential upside of […]
Analysts expect that Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) will post ($0.63) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have provided estimates for Relay Therapeutics’ earnings. The lowest EPS estimate is ($0.64) and the highest is ($0.63). Relay Therapeutics posted earnings of ($0.47) per share in the same quarter […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating)’s share price gapped down prior to trading on Wednesday after an insider sold shares in the company. The stock had previously closed at $34.88, but opened at $31.40. Relay Therapeutics shares last traded at $31.29, with a volume of 12,657 shares changing hands. Specifically, insider Donald A. Bergstrom […]